This study aims to develop and evaluate a digital twin (DT) framework to enhance adaptive proton therapy for prostate stereotactic body radiotherapy (SBRT), focusing on improving treatment precision for dominant intraprostatic lesions (DILs) while minimizing organ-at-risk (OAR) toxicity. We propose a decision-theoretic (DT) framework combining deep learning (DL)-based deformable image registration (DIR) with a prior treatment database to generate synthetic CTs (sCTs) for predicting interfractional anatomical changes. Using daily CBCT from five prostate SBRT patients with DILs, the framework precomputes multiple plans with high (DT-H) and low (DT-L) similarity sCTs. Plan optimization is performed in RayStation 2023B, assuming a constant RBE of 1.1 and robustly accounting for positional and range uncertainties. Plan quality is evaluated via a modified ProKnow score across two fractions, with reoptimization limited to 10 minutes. Daily CBCT evaluation showed clinical plans often violated OAR constraints (e.g., bladder V20.8Gy, rectum V23Gy), with DIL V100 < 90% in 2 patients, indicating SIFB failure. DT-H plans, using high-similarity sCTs, achieved better or comparable DIL/CTV coverage and lower OAR doses, with reoptimization completed within 10 min (e.g., DT-H-REopt-A score: 154.3-165.9). DT-L plans showed variable outcomes; lower similarity correlated with reduced DIL coverage (e.g., Patient 4: 84.7%). DT-H consistently outperformed clinical plans within time limits, while extended optimization brought DT-L and clinical plans closer to DT-H quality. This DT framework enables rapid, personalized adaptive proton therapy, improving DIL targeting and reducing toxicity. By addressing geometric uncertainties, it supports outcome gains in ultra-hypofractionated prostate RT and lays groundwork for future multimodal anatomical prediction.

Shortcut learning undermines model generalization to out-of-distribution data. While the literature attributes shortcuts to biases in superficial features, we show that imbalances in the semantic distribution of sample embeddings induce spurious semantic correlations, compromising model robustness. To address this issue, we propose SCISSOR (Semantic Cluster Intervention for Suppressing ShORtcut), a Siamese network-based debiasing approach that remaps the semantic space by discouraging latent clusters exploited as shortcuts. Unlike prior data-debiasing approaches, SCISSOR eliminates the need for data augmentation and rewriting. We evaluate SCISSOR on 6 models across 4 benchmarks: Chest-XRay and Not-MNIST in computer vision, and GYAFC and Yelp in NLP tasks. Compared to several baselines, SCISSOR reports +5.3 absolute points in F1 score on GYAFC, +7.3 on Yelp, +7.7 on Chest-XRay, and +1 on Not-MNIST. SCISSOR is also highly advantageous for lightweight models with ~9.5% improvement on F1 for ViT on computer vision datasets and ~11.9% for BERT on NLP. Our study redefines the landscape of model generalization by addressing overlooked semantic biases, establishing SCISSOR as a foundational framework for mitigating shortcut learning and fostering more robust, bias-resistant AI systems.

Background: Accurate lesion segmentation is critical for multiple sclerosis (MS) diagnosis, yet current deep learning approaches face robustness challenges. Aim: This study improves MS lesion segmentation by combining data fusion and deep learning techniques. Materials and Methods: We suggested novel radiomic features (concentration rate and R\'enyi entropy) to characterize different MS lesion types and fused these with raw imaging data. The study integrated radiomic features with imaging data through a ResNeXt-UNet architecture and attention-augmented U-Net architecture. Our approach was evaluated on scans from 46 patients (1102 slices), comparing performance before and after data fusion. Results: The radiomics-enhanced ResNeXt-UNet demonstrated high segmentation accuracy, achieving significant improvements in precision and sensitivity over the MRI-only baseline and a Dice score of 0.774$\pm$0.05; p<0.001 according to Bonferroni-adjusted Wilcoxon signed-rank tests. The radiomics-enhanced attention-augmented U-Net model showed a greater model stability evidenced by reduced performance variability (SDD = 0.18 $\pm$ 0.09 vs. 0.21 $\pm$ 0.06; p=0.03) and smoother validation curves with radiomics integration. Conclusion: These results validate our hypothesis that fusing radiomics with raw imaging data boosts segmentation performance and stability in state-of-the-art models.

Accurate segmentation and classification of brain tumors from Magnetic Resonance Imaging (MRI) remain key challenges in medical image analysis, largely due to the lack of high-quality, balanced, and diverse datasets. In this work, we present a new curated MRI dataset designed specifically for brain tumor segmentation and classification tasks. The dataset comprises 6,000 contrast-enhanced T1-weighted MRI scans annotated by certified radiologists and physicians, spanning three major tumor types-glioma, meningioma, and pituitary-as well as non-tumorous cases. Each sample includes high-resolution labels and is categorized across axial, sagittal, and coronal imaging planes to facilitate robust model development and cross-view generalization. To demonstrate the utility of the dataset, we propose a transformer-based segmentation model and benchmark it against established baselines. Our method achieves the highest weighted mean Intersection-over-Union (IoU) of 82.3%, with improvements observed across all tumor categories. Importantly, this study serves primarily as an introduction to the dataset, establishing foundational benchmarks for future research. We envision this dataset as a valuable resource for advancing machine learning applications in neuro-oncology, supporting both academic research and clinical decision-support development. datasetlink: https://www.kaggle.com/datasets/briscdataset/brisc2025/

Medical imaging plays a crucial role in assessing knee osteoarthritis (OA) risk by enabling early detection and disease monitoring. Recent machine learning methods have improved risk estimation (i.e., predicting the likelihood of disease progression) and predictive modelling (i.e., the forecasting of future outcomes based on current data) using medical images, but clinical adoption remains limited due to their lack of interpretability. Existing approaches that generate future images for risk estimation are complex and impractical. Additionally, previous methods fail to localize anatomical knee landmarks, limiting interpretability. We address these gaps with a new interpretable machine learning method to estimate the risk of knee OA progression via multi-task predictive modelling that classifies future knee OA severity and predicts anatomical knee landmarks from efficiently generated high-quality future images. Such image generation is achieved by leveraging a diffusion model in a class-conditioned latent space to forecast disease progression, offering a visual representation of how particular health conditions may evolve. Applied to the Osteoarthritis Initiative dataset, our approach improves the state-of-the-art (SOTA) by 2\%, achieving an AUC of 0.71 in predicting knee OA progression while offering ~9% faster inference time.

Accurate diagnosis of brain disorders such as Alzheimer's disease and brain tumors remains a critical challenge in medical imaging. Conventional methods based on manual MRI analysis are often inefficient and error-prone. To address this, we propose DGG-XNet, a hybrid deep learning model integrating VGG16 and DenseNet121 to enhance feature extraction and classification. DenseNet121 promotes feature reuse and efficient gradient flow through dense connectivity, while VGG16 contributes strong hierarchical spatial representations. Their fusion enables robust multiclass classification of neurological conditions. Grad-CAM is applied to visualize salient regions, enhancing model transparency. Trained on a combined dataset from BraTS 2021 and Kaggle, DGG-XNet achieved a test accuracy of 91.33\%, with precision, recall, and F1-score all exceeding 91\%. These results highlight DGG-XNet's potential as an effective and interpretable tool for computer-aided diagnosis (CAD) of neurodegenerative and oncological brain disorders.

Synthesizing high quality CT images remains a signifi-cant challenge due to the limited availability of annotat-ed data and the complex nature of CT imaging. In this work, we present PRO, a novel framework that, to the best of our knowledge, is the first to perform CT image synthesis in the projection domain using latent diffusion models. Unlike previous approaches that operate in the image domain, PRO learns rich structural representa-tions from raw projection data and leverages anatomi-cal text prompts for controllable synthesis. This projec-tion domain strategy enables more faithful modeling of underlying imaging physics and anatomical structures. Moreover, PRO functions as a foundation model, capa-ble of generalizing across diverse downstream tasks by adjusting its generative behavior via prompt inputs. Experimental results demonstrated that incorporating our synthesized data significantly improves perfor-mance across multiple downstream tasks, including low-dose and sparse-view reconstruction, even with limited training data. These findings underscore the versatility and scalability of PRO in data generation for various CT applications. These results highlight the potential of projection domain synthesis as a powerful tool for data augmentation and robust CT imaging. Our source code is publicly available at: https://github.com/yqx7150/PRO.

Dental diagnosis relies on two primary imaging modalities: panoramic radiographs (PX) providing 2D oral cavity representations, and Cone-Beam Computed Tomography (CBCT) offering detailed 3D anatomical information. While PX images are cost-effective and accessible, their lack of depth information limits diagnostic accuracy. CBCT addresses this but presents drawbacks including higher costs, increased radiation exposure, and limited accessibility. Existing reconstruction models further complicate the process by requiring CBCT flattening or prior dental arch information, often unavailable clinically. We introduce ViT-NeBLa, a vision transformer-based Neural Beer-Lambert model enabling accurate 3D reconstruction directly from single PX. Our key innovations include: (1) enhancing the NeBLa framework with Vision Transformers for improved reconstruction capabilities without requiring CBCT flattening or prior dental arch information, (2) implementing a novel horseshoe-shaped point sampling strategy with non-intersecting rays that eliminates intermediate density aggregation required by existing models due to intersecting rays, reducing sampling point computations by $52 \%$, (3) replacing CNN-based U-Net with a hybrid ViT-CNN architecture for superior global and local feature extraction, and (4) implementing learnable hash positional encoding for better higher-dimensional representation of 3D sample points compared to existing Fourier-based dense positional encoding. Experiments demonstrate that ViT-NeBLa significantly outperforms prior state-of-the-art methods both quantitatively and qualitatively, offering a cost-effective, radiation-efficient alternative for enhanced dental diagnostics.

Chest radiography is widely used in diagnostic imaging. However, perceptual errors -- especially overlooked but visible abnormalities -- remain common and clinically significant. Current workflows and AI systems provide limited support for detecting such errors after interpretation and often lack meaningful human--AI collaboration. We introduce RADAR (Radiologist--AI Diagnostic Assistance and Review), a post-interpretation companion system. RADAR ingests finalized radiologist annotations and CXR images, then performs regional-level analysis to detect and refer potentially missed abnormal regions. The system supports a "second-look" workflow and offers suggested regions of interest (ROIs) rather than fixed labels to accommodate inter-observer variation. We evaluated RADAR on a simulated perceptual-error dataset derived from de-identified CXR cases, using F1 score and Intersection over Union (IoU) as primary metrics. RADAR achieved a recall of 0.78, precision of 0.44, and an F1 score of 0.56 in detecting missed abnormalities in the simulated perceptual-error dataset. Although precision is moderate, this reduces over-reliance on AI by encouraging radiologist oversight in human--AI collaboration. The median IoU was 0.78, with more than 90% of referrals exceeding 0.5 IoU, indicating accurate regional localization. RADAR effectively complements radiologist judgment, providing valuable post-read support for perceptual-error detection in CXR interpretation. Its flexible ROI suggestions and non-intrusive integration position it as a promising tool in real-world radiology workflows. To facilitate reproducibility and further evaluation, we release a fully open-source web implementation alongside a simulated error dataset. All code, data, demonstration videos, and the application are publicly available at https://github.com/avutukuri01/RADAR.

Brain metastases are a common complication of systemic cancer, affecting over 20% of patients with primary malignancies. Longitudinal magnetic resonance imaging (MRI) is essential for diagnosing patients, tracking disease progression, assessing therapeutic response, and guiding treatment selection. However, the manual review of longitudinal imaging is time-intensive, especially for patients with multifocal disease. Artificial intelligence (AI) offers opportunities to streamline image evaluation, but developing robust AI models requires comprehensive training data representative of real-world imaging studies. Thus, there is an urgent necessity for a large dataset with heterogeneity in imaging protocols and disease presentation. To address this, we present an open-access dataset of 11,884 longitudinal brain MRI studies from 1,430 patients with clinically confirmed brain metastases, paired with clinical and image metadata. The provided dataset will facilitate the development of AI models to assist in the long-term management of patients with brain metastasis.